Recently, the Hubei Provincial Department of Economy and Information Technology announced the list of advanced intelligent factories in 2024 for intelligent factory gradient cultivation. Hubei Tianshu Pharmaceutical Co., Ltd. (Tianshu Pharmaceutical) was successfully selected into the list.
This selection is jointly promoted by six ministries and commissions including the Ministry of Industry and Information Technology, the National Development and Reform Commission, and the Ministry of Finance, aiming to accelerate the development of intelligent factories. Participating enterprises must meet a series of strict conditions, such as being qualified as above-scale industrial enterprises, having good operating and financial conditions, no bad credit records or illegal acts, and using safe and controllable key technical equipment and solutions.
Since its establishment, Tianshu Pharmaceutical has been committed to building an intelligent factory, proactively carrying out strategic layout around the main line of informatization and digitalization, actively promoting production intelligence, warehouse automation, and operation digitalization, and continuously introducing a number of modern intelligent systems. At present, it has realized the centralized control and management of multi-faceted and multi-level systems such as personnel positioning system, DCS (Distributed Control System) (intelligent control) system, SIS (Safety Instrumented System) (safety early warning and monitoring) system, intelligent warehousing system, and smart safety supervision platform. Operators can timely and comprehensively grasp the production, safety and other information of the entire factory. In scenarios such as factory construction, production operations, and safety management and control, Tianshu Pharmaceutical adopts advanced domestic and foreign intelligent technologies, equipment, and systems. Through a series of intelligent measures such as multi-parameter control, rich fed-batch modes, and intelligent central control systems, it has basically realized the intelligent manufacturing of characteristic APIs and advanced pharmaceutical intermediates, promoting the continuous improvement of product market competitiveness.
This selection as an advanced intelligent factory is the government's recognition of Tianshu Pharmaceutical's outstanding performance and technological innovation capability in the field of intelligent manufacturing. In the future, the company will further deepen the layout of intelligent manufacturing, actively embrace innovative technologies, use new technologies to serve production, make production greener and safer, and thus continuously improve the core competitiveness of products and the company's sustainable development capability.
